A detailed history of Clearline Capital LP transactions in Globus Medical Inc stock. As of the latest transaction made, Clearline Capital LP holds 63,777 shares of GMED stock, worth $5.22 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
63,777
Previous 314,969 79.75%
Holding current value
$5.22 Million
Previous $21.6 Million 78.85%
% of portfolio
0.2%
Previous 0.62%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$67.08 - $73.92 $16.8 Million - $18.6 Million
-251,192 Reduced 79.75%
63,777 $4.56 Million
Q2 2024

Aug 14, 2024

SELL
$49.79 - $68.85 $8.3 Million - $11.5 Million
-166,635 Reduced 34.6%
314,969 $21.6 Million
Q1 2024

May 15, 2024

BUY
$51.15 - $56.52 $7.17 Million - $7.92 Million
140,149 Added 41.04%
481,604 $25.8 Million
Q4 2023

Feb 14, 2024

BUY
$43.79 - $55.14 $2.66 Million - $3.36 Million
60,852 Added 21.69%
341,455 $18.2 Million
Q3 2023

Nov 14, 2023

BUY
$49.1 - $62.37 $13.8 Million - $17.5 Million
280,603 New
280,603 $13.9 Million

Others Institutions Holding GMED

About GLOBUS MEDICAL INC


  • Ticker GMED
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 77,037,200
  • Market Cap $6.3B
  • Description
  • Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...
More about GMED
Track This Portfolio

Track Clearline Capital LP Portfolio

Follow Clearline Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearline Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Clearline Capital LP with notifications on news.